Evaluation of the Combination of a Biofilm-Disrupting Agent and Negative Pressure Wound Therapy: A Case Series


Incorporating Point-of-Care Bacterial Fluorescence into a Wound Clinic Antimicrobial Stewardship Program


Results from 350-Patient FLAAG Trial Show MolecuLight Point-of-Care Imaging Improves Detection of High Bacterial Burden in Wounds Four-fold over Standard of Care Assessment

Press Release_Results of FLAAG Trial Show MolecuLight Provides 4x Improvement in Bacterial Detectio _Sept 29 2020_Final

Diagnostic Accuracy of Point-of-Care Fluorescence Imaging for the Detection of Bacterial Burden in Wounds: Results from the 350- Patient FLAAG Trial